Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results
Go back to Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results| (NASDAQ: CMPX) | Delayed: 2.41 +0.10 (4.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.31 | 52 Week High | $ | |||
| Open | $2.31 | 52 Week Low | $ | |||
| Day High | $2.46 | P/E | N/A | |||
| Day Low | $2.31 | EPS | $ | |||
| Volume | 1,445,048 | |||||
